 |
|
Impact of Anti-Tuberculosis Drug Use on Treatment Outcomes in Patients with Pulmonary Fluoroquinolone-Resistant Multidrug-Resistant Tuberculosis: A Nationwide Retrospective Cohort Study with Propensity Score Matching
Hongjo Choi, Dawoon Jeong, Young Ae Kang, Doosoo Jeon, Hee-Yeon Kang, Hee Jin Kim, Hee-Sun Kim, Jeongha Mok
Tuberc Respir Dis. 2023;86(3):234-244. Published online 2023 May 31 DOI: https://doi.org/10.4046/trd.2023.0040
|
|
Citations to this article as recorded by
 Treatment Outcomes of Fluoroquinolone-Resistant Multidrug-Resistant Tuberculosis: An Implication for Delamanid
Oki Nugraha Putra, Telly Purnamasari
Tuberculosis and Respiratory Diseases.2024; 87(2): 206. CrossRef Treatment Outcomes of Fluoroquinolone- Resistant Multidrug-Resistant Tuberculosis: An Implication for Delamanid - Authors’ Reply
Saerom Kim, Jeongha Mok
Tuberculosis and Respiratory Diseases.2024; 87(2): 209. CrossRef
|